GramEye is a healthtech firm that develops medical devices that automates gram stain with deep learning and robotics.
GramEye has raised $3.6M in total funding. The most recent round was Series B. The last funding was announced in November 2025.
GramEye's investors include Beyond Next Ventures, Samurai Incubate, NEDO, NES Venture Capital.
GramEye is headquartered in Ibaraki, Japan.
GramEye is a healthtech firm that develops medical devices that automates gram stain with deep learning and robotics.
GramEye is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"GramEye — Funding & Investors." VCBacked, November 21, 2025, https://www.vcbacked.co/company/grameye. Accessed August 1, 2026.
VCBacked. (2025). GramEye — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/grameye
{{cite web |title=GramEye — Funding & Investors |url=https://www.vcbacked.co/company/grameye |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated